Why the study?
Concepts regarding the substrate and triggers of atrial fibrillation have changed, highlighting the role of concomitant diseases like chronic obstructive pulmonary disease and arterial hypertension.
Key points are not available for this paper at this time.
Design
Literature review
This review highlights the importance of managing comorbidities like COPD and hypertension to prevent the development and progression of atrial fibrillation.
The article presents a review of the literature, reflecting ideas about the effect of chronic obstructive pulmonary disease on the development and progression of atrial fibrillation. Modern concepts regarding the substrate and triggers of paroxysms of atrial fibrillation have recently changed significantly. The role of concomitant diseases, in particular arterial hypertension and chronic obstructive pulmonary disease, formed the basis for changes in the electrophysiological properties of the myocardium.
No takes yet. Share an insight, caveat, or question.
Хидирова et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: